Real World Evidence Solutions Research Report 2026: $4.81 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, And Forecasts, 2020-2025, 2025-2030F, 2035F

(MENAFN- GlobeNewsWire - Nasdaq) Key opportunities in the real-world evidence solutions market include integration of AI and advanced analytics, precision medicine expansion, and geriatric population growth. Rising demand for post-approval evidence and regulatory decision-making drive market evolution, with Asia-Pacific as a leading growth region.

Dublin, April 24, 2026 (GLOBE NEWSWIRE) -- The "Real World Evidence Solutions Market Report 2026" has been added to ResearchAndMarkets's offering.

The Real-World Evidence (RWE) Solutions Market is experiencing significant growth, projected to expand from $2.33 billion in 2025 to $2.7 billion by 2026, with a CAGR of 15.9%. This upsurge is primarily driven by the increased availability of comprehensive healthcare data and the growing importance of post-market safety monitoring, bolstered by regulatory bodies' early acceptance of RWE. The market is anticipated to further escalate to $4.81 billion by 2030, growing at a CAGR of 15.6%. This forecasted growth is facilitated by the integration of health data analytics in regulatory frameworks, heightened reimbursement decisions influenced by RWE, and advancements in precision medicine initiatives.

Key trends shaping the market include the adoption of AI-enabled evidence platforms and the expanded use of advanced analytics. This is matched by a growing integration of electronic health records (EHR) and claims data, fueling enhanced post-market safety surveillance. The expanding geriatric demographic is also pivotal to market growth, as this population encounters higher health risks, increasing the demand for effective healthcare solutions. According to the Population Reference Bureau, the American populace aged 65 and older is expected to rise from 58 million in 2022 to 82 million by 2050, elevating their share of the total population from 17% to 23%.

Prominent companies, such as Maxis Clinical Sciences, are pioneering RWE solutions to boost evidence-based medicine, introducing services integrating multiple real-world data sources like patient-reported outcomes and wearable device data, enhancing patient engagement and data quality. Recent strategic moves in the industry include eMed LLC's acquisition of Science 37 Holdings Inc. for $5.75 per share, aimed at improving eMed's RWE capabilities through Science 37's decentralized Metasite platform.

Leading organizations in this sector include Anthem Inc., Cegedim Health Data, Oracle Corporation, and UnitedHealth Group Incorporated, among others. North America remains the largest region in this market as of 2025, although Asia-Pacific is expected to register the fastest growth during the forecast period.

Current geopolitical trades, particularly tariffs, are impacting the market by escalating the costs of essential data infrastructure and cloud services used extensively in healthcare data processing. These increases predominantly affect North American and European companies dependent on international digital infrastructure, while encouraging local data hosting and regional analytics development, which positively influences long-term market resilience.

Emerging RWE solutions capitalize on diverse data sources, including EHRs and patient registries, facilitating enhanced evaluation of medical treatments' safety and effectiveness in real-world settings. These services span across therapeutic areas such as oncology and cardiovascular diseases, catering to pharmaceutical companies and healthcare providers aiming for regulatory approvals and post-market safety monitoring.

The RWE Solutions Market represents a vital frontier in the healthcare sector, enabling insights that inform regulatory decisions and healthcare improvements globally.

Key Attributes:

Report Attribute	Details
No. of Pages	250
Forecast Period	2026 - 2030
Estimated Market Value (USD) in 2026	$2.7 Billion
Forecasted Market Value (USD) by 2030	$4.81 Billion
Compound Annual Growth Rate	15.6%
Regions Covered	Global

Report Scope:

• Component: Services, Data Sets, Clinical Setting Data, Claims Data, Pharmacy Data, Patient Powered Data
• Therapeutic Area: Oncology, Cardiovascular, Neurology, Immunology, Other Therapeutic Areas
• Application: Drug Development, Medical Device Development, Post Market Safety Monitoring
• End-Users: Pharmaceutical Companies, Healthcare Providers, Payers, Other End-Users

Subsegments:

• Services: Consulting, Data Management, Regulatory, Analytics
• Data Sets: Electronic Health Records, Patient Registries, Clinical Trials Data, Observational Study Data
• Clinical Setting Data: Hospital, Outpatient, Specialty Care, Claims Data
• Insurance Claims Data: Medicare/Medicaid, Commercial Claims
• Prescription Data: Pharmacy Claims, Drug Utilization
• Patient Powered Data: Surveys, PRO, Wearable Data

Companies Featured

• Anthem Inc.
• Cegedim Health Data
• Clarivate PLC
• Cognizant Technology Solutions Corporation
• Flatiron Health Inc.
• International Business Machines Corporation
• ICON plc
• IQVIA Holdings Inc.
• Medpace Holdings Inc.
• Optum Inc.
• Oracle Corporation
• PAREXEL International Corporation
• PPD Inc.
• SAS Institute Inc.
• Syneos Health
• Symphony Innovation LLC
• UnitedHealth Group Incorporated
• Deloitte Touche Tohmatsu Limited
• Informa PLC
• Palantir Technologies
• UDG Healthcare PLC
• Elevance Health Inc.
• Covance Consulting Ltd.
• Clinipace Worldwide
• Evidera Inc.
• Pharmerit International
• Analysis Group Inc.
• HealthCore Inc.
• Inovalon Holdings Inc.
• KMK Consulting Inc.

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Real World Evidence Solutions Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN24042026004107003653ID1111027059